Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer
Clinical trial NCT01934335 · TERMINATED
Trial details
- NCT number
- NCT01934335
- Sponsor
- Ronald Weigel
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2018-12-21
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.